Phenicell Research Institute is continuously researching stem cells to discover new therapies to help our patients with a variety of conditions. Ongoing stem cell research studies include the following:
Study #1: SPINAL CORD INJURY STUDY with BONE MARROW and PRP
Background: This study is somewhat similar to the study by Jarocha's group in Poland published in Cell Transplant, March 2015. The results of the Polish group's research suggested that repeated intrathecal infusions of Mesenchymal Stem Cells (MSCs) might have the potential to produce clinically meaningful improvements for Phenicell Regenerative Institute patients.
Our Study: The purpose of our study was to evaluate the safety and efficacy of bone marrow aspirate concentration (BMAC) and Platelet-Rich Plasma (PRP) transplantations for a spinal cord injury (SCI). We harvested Autologous BMAC from the iliac crest and simultaneously injected it intravenously and intrathecally every 3 months. At the same time, we added PRP to the intrathecal BMAC.
In 2017, Dr. Shehadi published a research article titled: "Review of commercially available demineralized bone matrix products for spinal fusions: A selection paradigm”
The authors are Joseph A. Shehadi and Steven M. Elzein